Our data identified the steady-state decline in DNMT3A as a contributing factor to the enhanced production of IL-1α by monocytic cells, providing novel mechanistic evidence for the relationship between CHIP, inflammaging, and lung cancer. Here, DNMT3A is linked to lung cancer.